We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
76
PUT
Thermo Fisher Scientific
TMO
$223B
$9.13M 0.26%
20,000
– –
NARI
77
DELISTED
Inari Medical, Inc. Common Stock
NARI
$9.1M 0.26%
85,000
-10,000
-11% -$1.04M
CGEM icon
78
Cullinan Oncology
CGEM
$1.26B
$9.03M 0.26%
+216,630
New +$8.79M
INCY icon
79
Incyte
INCY
$24.5B
$9M 0.26%
+110,750
New +$9.45M
INOV
80
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$8.73M 0.25%
303,500
-533,100
-64% -$13.7M
CRL icon
81
PUT
Charles River Laboratories
CRL
$13.6B
$8.7M 0.25%
+30,000
New +$8.34M
CNMD icon
82
CONMED
CNMD
$1.48B
$8.49M 0.24%
65,000
-48,802
-43% -$5.87M
MRVI icon
83
Maravai LifeSciences
MRVI
$861M
$8.42M 0.24%
236,350
-20,650
-8% -$684K
RVTY icon
84
PUT
Revvity
RVTY
$13.2B
$8.34M 0.24%
+65,000
New +$9M
COO icon
85
Cooper Companies
COO
$15B
$8.31M 0.24%
+86,584
New +$8.22M
TFX icon
86
PUT
Teleflex
TFX
$6.03B
$8.31M 0.24%
20,000
+5,000
+33% +$2M
ICAD
87
DELISTED
iCAD Inc
ICAD
$8.24M 0.23%
+388,193
New +$6.54M
BNGO icon
88
Bionano Genomics
BNGO
$13.8M
$8.08M 0.23%
1,667
-1,833
-52% -$10.3M
TALK icon
89
Talkspace
TALK
$869M
$8.02M 0.23%
+808,089
New +$8.78M
QTNT
90
DELISTED
Quotient Limited Ordinary Shares
QTNT
$8.01M 0.23%
54,410
-14,796
-21% -$2.92M
OCDX
91
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$7.99M 0.23%
+413,891
New +$7.29M
ZBH icon
92
CALL
Zimmer Biomet
ZBH
$18.7B
$7.97M 0.23%
51,294
+20,394
+66% +$3.16M
GKOS icon
93
Glaukos
GKOS
$11B
$7.76M 0.22%
92,500
+7,500
+9% +$660K
MRK icon
94
CALL
Merck
MRK
$328B
$7.71M 0.22%
+104,800
New +$7.73M
CYRX icon
95
PUT
CryoPort
CYRX
$750M
$7.69M 0.22%
+147,800
New +$8.99M
ABCL icon
96
AbCellera Biologics
ABCL
$3.18B
$7.64M 0.22%
225,000
-140,000
-38% -$5.58M
RCEL icon
97
Avita Medical
RCEL
$251M
$7.6M 0.22%
+383,589
New +$8.92M
HOLX
98
PUT
DELISTED
Hologic
HOLX
$7.44M 0.21%
100,000
+60,000
+150% +$4.56M
KRA
99
CALL
DELISTED
Kraton Corporation
KRA
$7.41M 0.21%
202,500
+77,500
+62% +$2.77M
MASS icon
100
908 Devices
MASS
$414M
$7.21M 0.21%
148,767
+8,767
+6% +$501K
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.